4//SEC Filing
Huizenga Theodore Alan 4
Accession 0000950170-25-113446
CIK 0001515673other
Filed
Sep 7, 8:00 PM ET
Accepted
Sep 8, 2:01 PM ET
Size
5.0 KB
Accession
0000950170-25-113446
Insider Transaction Report
Form 4
Huizenga Theodore Alan
Controller and PAO
Transactions
- Sale
Common Stock
2025-09-05$31.39/sh−84$2,637→ 50,306 total
Footnotes (3)
- [F1]Represents shares sold to pay required tax withholdings due to the vesting of RSUs.
- [F2]Includes 266 shares acquired under the Company's A&R 2014 Employee Stock Purchase Plan on April 30, 2025.
- [F3]Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.
Documents
Issuer
Ultragenyx Pharmaceutical Inc.
CIK 0001515673
Entity typeother
Related Parties
1- filerCIK 0001603347
Filing Metadata
- Form type
- 4
- Filed
- Sep 7, 8:00 PM ET
- Accepted
- Sep 8, 2:01 PM ET
- Size
- 5.0 KB